This article identifies three oversold financial stocks with RSI values below 30, suggesting potential buying opportunities. The article provides insights into recent company performance, price action, and potential breakout signals.
Results for: RSI Indicator
As of April 26, 2024, four stocks in the health care sector appear to be overbought according to the Relative Strength Index (RSI) indicator, which suggests they may be due for a pullback. These stocks are Fusion Pharmaceuticals Inc. (FUSN), AstraZeneca PLC (AZN), Boston Scientific Corporation (BSX), and Elevance Health, Inc. (ELV). Investors who rely on momentum as a trading strategy may want to consider taking profits or hedging their positions in these stocks.